NewsRx

Search our medical news database

LuMend, Inc.

Company launches Frontrunner XP CTO catheter platform

Published in Cardiovascular Business Week, July 6th, 2004

LuMend, Inc., a company developing solutions to treat chronic total occlusions (CTO), is launching the Frontrunner XP CTO catheter platform as part of their new peripheral vascular strategic initiatives.

The XP family of catheters is based on the Frontrunner X39 coronary CTO Catheter and is designed to provide enhanced performance in crossing occlusions in the peripheral vasculature. The Frontrunner family of products utilizes a proprietary blunt micro dissection technology to improve the physician's ability to cross CTOs.

The new 4.5 french Frontrunner XP CTO Catheter is designed to address the unique demands associated with the specific anatomical...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook